Molecular Basis of Thyroid Cancer

  • Nadir R. Farid

Part of the Cancer Treatment and Research book series (CTAR, volume 122)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Evan Y. Yu, William C. Hahn
    Pages 1-22
  3. Sylvia L. Asa
    Pages 23-68
  4. Runjan Chetty
    Pages 69-84
  5. Martin Schlumberger
    Pages 107-120
  6. Judy L. Meinkoth
    Pages 131-148
  7. Nadir R. Farid
    Pages 149-164
  8. Yufei Shi, Minjing Zou
    Pages 179-190
  9. Angela Greco, Emanuela Roccato, Marco A. Pierotti
    Pages 207-219
  10. Orsolya Dohán, Nancy Carrasco
    Pages 221-236
  11. Nicholas J. Sarlis, Salvatore Benvenga
    Pages 237-264
  12. Laszlo Puskas, Nadir R. Farid
    Pages 265-271
  13. Carsten Boltze
    Pages 273-293
  14. Matthew D. Ringel
    Pages 295-316
  15. T. T. H. Phan, P. L. Jager, K. M. van Tol, T. P. Links
    Pages 317-343
  16. Yuji Nagayama
    Pages 369-379
  17. Carl D. Malchoff, Diana M. Malchoff
    Pages 381-387
  18. Marco A. Pierotti, Elena Arighi, Debora Degl’innocenti, Maria Grazia Borrello
    Pages 389-415
  19. Lois M. Mulligan
    Pages 417-428
  20. Back Matter
    Pages 429-444

About this book


Thyroid cancer shows the fastest rate of increase in women in the USA. There is an urgent need to better understand its underlying causes, explore efficient and sensitive methods for its diagnosis, new methods of treatment and follow-up, based on the recent advances in technology.

Molecular Basis of thyroid Cancer brings together top-flight experts from across the globe to consider present state of the art treatment and techniques and what the future holds. The product of this effort is invaluable to endocrinologists, particularly those with an interest in the thyroid, molecular oncologists, nuclear medicine physicians and those in biotechnology intent on devising innovative therapies for cancer.

"Significant advances in our understanding of thyroid cancer have occurred over the previous decade. This text discusses the molecular alterations and pathologic manifestations seen in this disease. Distinguished investigators address both the basic biology and clinical issues pertinent to our understanding and management of patients with thyroid cancer."

Steven T. Rosen, M.D.

Series Editor


carcinogenesis carcinoma cell gene therapy growth growth factor hormone hormones imaging lymphoma nuclear receptors pathology protein

Editors and affiliations

  • Nadir R. Farid
    • 1
  1. 1.Osancor Biotech, Inc.WatfordUK

Bibliographic information

  • DOI
  • Copyright Information Springer Science + Business Media, Inc. 2005
  • Publisher Name Springer, Boston, MA
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-1-4020-8106-4
  • Online ISBN 978-1-4020-8107-1
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site